TRVI (STOCKS)
Trevi Therapeutics, Inc. Common Stock
$13.330000
+0.140000 (+1.06%)
Prev close: $13.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jennifer L. Good
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,710.89M
- Employees
- 33
- P/E (TTM)
- -41.55
- P/B (TTM)
- 9.24
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.06 | $-0.10 | +0.0401 | +40.06% |
|
Sep 2025 (Q3)
|
$-0.08 | $-0.10 | +0.0203 | +20.24% |
|
Jun 2025 (Q2)
|
$-0.09 | $-0.10 | +0.0130 | +12.62% |
|
Mar 2025 (Q1)
|
$-0.09 | $-0.12 | +0.0335 | +27.13% |